Rightsmile, Inc. (RIGH)

[john12341]

budgenius will prevail.

the U.S. Drug Enforcement Agency (DEA) may have opened the door to removing marijuana from its current listing as a Schedule I drug.

In a letter last Monday to Senator Elizabeth Warren and other U.S. Senators, the U.S. Drug Enforcement Agency (DEA) may have opened the door to removing marijuana from its current listing as a Schedule I drug. Such a move would, among other things, allow more scientific research into both the health risks and therapeutic benefits of marijuana.

That was the focus of the agency’s letter, but delisting marijuana from Schedule I could also open the door for marijuana companies to create bank accounts and to claim business-related expenses when they file their tax returns. Reclassifying marijuana as a Schedule II drug would allow more research and offer additional protection to cannabis-related companies and patients. Reclassifying marijuana as a Schedule III drug would remove the current tax code restrictions.

Some observers of the DEA are not sanguine. At reason.com, Jacob Sullum recalled the DEA’s history of foot dragging on petitions to reschedule marijuana, noting that the agency has already rejected 3 rescheduling petitions after delays from 6 to 16 years. A fourth petition, filed in 2009 and a fifth filed in 2011, are still pending.

Sullum also noted that a schedule change would require a major change in the way the DEA interprets the Controlled Substances Act which he believes is unlikely to occur because it would require the agency to reverse itself on the basis of little to no new evidence. A third reason not to expect a change is that President Obama has said that marijuana will be reclassified only by Congressional action. Good luck with that

.

source
http://247wallst.com/consumer-products/2016/04/10/marijuana-weekly-news-roundup-37/